MXPA99011488A - Perfumed compositions and methods for reducing body odors and excess moisture - Google Patents
Perfumed compositions and methods for reducing body odors and excess moistureInfo
- Publication number
- MXPA99011488A MXPA99011488A MXPA/A/1999/011488A MX9911488A MXPA99011488A MX PA99011488 A MXPA99011488 A MX PA99011488A MX 9911488 A MX9911488 A MX 9911488A MX PA99011488 A MXPA99011488 A MX PA99011488A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- perfume
- cyclodextrin
- skin
- odor
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 198
- 208000035985 Body Odor Diseases 0.000 title claims description 23
- 238000000034 method Methods 0.000 title claims description 21
- 239000002304 perfume Substances 0.000 claims abstract description 137
- 229920000858 Cyclodextrin Polymers 0.000 claims description 61
- 239000004615 ingredient Substances 0.000 claims description 50
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 39
- 239000000843 powder Substances 0.000 claims description 37
- -1 skin protectants Substances 0.000 claims description 36
- 239000002245 particle Substances 0.000 claims description 26
- 206010040904 Skin odour abnormal Diseases 0.000 claims description 14
- 239000006096 absorbing agent Substances 0.000 claims description 14
- 239000007921 spray Substances 0.000 claims description 14
- 239000010457 zeolite Substances 0.000 claims description 13
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 11
- 238000004140 cleaning Methods 0.000 claims description 11
- 230000001166 anti-perspirative effect Effects 0.000 claims description 10
- 239000003213 antiperspirant Substances 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 239000001116 FEMA 4028 Substances 0.000 claims description 9
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 9
- 229960004853 betadex Drugs 0.000 claims description 9
- 239000003974 emollient agent Substances 0.000 claims description 9
- 239000004599 antimicrobial Substances 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 8
- 239000004744 fabric Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 239000002250 absorbent Substances 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 210000004197 pelvis Anatomy 0.000 claims description 6
- 210000001215 vagina Anatomy 0.000 claims description 6
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 5
- 230000002745 absorbent Effects 0.000 claims description 5
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims description 5
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 5
- 150000004760 silicates Chemical class 0.000 claims description 5
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims description 4
- 206010046935 Vaginal odour Diseases 0.000 claims description 4
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims description 4
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims description 4
- 238000009826 distribution Methods 0.000 claims description 3
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000005549 size reduction Methods 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims 1
- 241000238366 Cephalopoda Species 0.000 abstract 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 75
- 210000003491 skin Anatomy 0.000 description 63
- 235000019645 odor Nutrition 0.000 description 50
- 239000000377 silicon dioxide Substances 0.000 description 35
- 229940022663 acetate Drugs 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 21
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 20
- 229920002472 Starch Polymers 0.000 description 19
- 229940008099 dimethicone Drugs 0.000 description 19
- 239000004205 dimethyl polysiloxane Substances 0.000 description 19
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 19
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 19
- 229960003500 triclosan Drugs 0.000 description 19
- 235000019698 starch Nutrition 0.000 description 18
- 239000008107 starch Substances 0.000 description 18
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 17
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 14
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 14
- 239000004005 microsphere Substances 0.000 description 14
- 229920002261 Corn starch Polymers 0.000 description 13
- 239000008120 corn starch Substances 0.000 description 13
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 12
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 12
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 12
- 239000003094 microcapsule Substances 0.000 description 12
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 11
- 229920000299 Nylon 12 Polymers 0.000 description 11
- 229940097362 cyclodextrins Drugs 0.000 description 11
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 239000003981 vehicle Substances 0.000 description 10
- 239000004698 Polyethylene Substances 0.000 description 9
- 235000012241 calcium silicate Nutrition 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 229920000573 polyethylene Polymers 0.000 description 9
- 239000000378 calcium silicate Substances 0.000 description 8
- 229910052918 calcium silicate Inorganic materials 0.000 description 8
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 8
- 238000005538 encapsulation Methods 0.000 description 8
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- MDHYEMXUFSJLGV-UHFFFAOYSA-N phenethyl acetate Chemical compound CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 8
- QUMXDOLUJCHOAY-UHFFFAOYSA-N 1-Phenylethyl acetate Chemical compound CC(=O)OC(C)C1=CC=CC=C1 QUMXDOLUJCHOAY-UHFFFAOYSA-N 0.000 description 7
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 7
- 239000001095 magnesium carbonate Substances 0.000 description 7
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 239000011787 zinc oxide Substances 0.000 description 7
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 6
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 6
- 239000000443 aerosol Substances 0.000 description 6
- 239000003908 antipruritic agent Substances 0.000 description 6
- 229940007550 benzyl acetate Drugs 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 6
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 6
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 6
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 6
- 229930007744 linalool Natural products 0.000 description 6
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 6
- 229940067107 phenylethyl alcohol Drugs 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000000454 talc Substances 0.000 description 6
- 235000012222 talc Nutrition 0.000 description 6
- 229910052623 talc Inorganic materials 0.000 description 6
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 5
- 241001116389 Aloe Species 0.000 description 5
- 239000005792 Geraniol Substances 0.000 description 5
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 5
- 241000234269 Liliales Species 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- 229910021536 Zeolite Inorganic materials 0.000 description 5
- 235000011399 aloe vera Nutrition 0.000 description 5
- YPZUZOLGGMJZJO-UHFFFAOYSA-N ambrofix Natural products C1CC2C(C)(C)CCCC2(C)C2C1(C)OCC2 YPZUZOLGGMJZJO-UHFFFAOYSA-N 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 239000002781 deodorant agent Substances 0.000 description 5
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 229940113087 geraniol Drugs 0.000 description 5
- IPWBXORAIBJDDQ-UHFFFAOYSA-N methyl 2-hexyl-3-oxocyclopentane-1-carboxylate Chemical compound CCCCCCC1C(C(=O)OC)CCC1=O IPWBXORAIBJDDQ-UHFFFAOYSA-N 0.000 description 5
- 235000010446 mineral oil Nutrition 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- 229940033134 talc Drugs 0.000 description 5
- 239000005995 Aluminium silicate Substances 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 4
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 4
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 4
- 239000005770 Eugenol Substances 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- XXIKYCPRDXIMQM-UHFFFAOYSA-N Isopentenyl acetate Chemical compound CC(C)=CCOC(C)=O XXIKYCPRDXIMQM-UHFFFAOYSA-N 0.000 description 4
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 description 4
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 description 4
- 235000012211 aluminium silicate Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 4
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 4
- 230000000536 complexating effect Effects 0.000 description 4
- XSNQECSCDATQEL-UHFFFAOYSA-N dihydromyrcenol Chemical compound C=CC(C)CCCC(C)(C)O XSNQECSCDATQEL-UHFFFAOYSA-N 0.000 description 4
- 229930008394 dihydromyrcenol Natural products 0.000 description 4
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 4
- 229960002217 eugenol Drugs 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 4
- SDQFDHOLCGWZPU-UHFFFAOYSA-N lilial Chemical compound O=CC(C)CC1=CC=C(C(C)(C)C)C=C1 SDQFDHOLCGWZPU-UHFFFAOYSA-N 0.000 description 4
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 4
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 description 4
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 4
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 4
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 4
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 4
- 235000012141 vanillin Nutrition 0.000 description 4
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 4
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 4
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 description 4
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 4
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 3
- VPKMGDRERYMTJX-CMDGGOBGSA-N 1-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-1-penten-3-one Chemical compound CCC(=O)\C=C\C1C(C)=CCCC1(C)C VPKMGDRERYMTJX-CMDGGOBGSA-N 0.000 description 3
- OFHHDSQXFXLTKC-UHFFFAOYSA-N 10-undecenal Chemical compound C=CCCCCCCCCC=O OFHHDSQXFXLTKC-UHFFFAOYSA-N 0.000 description 3
- WWJLCYHYLZZXBE-UHFFFAOYSA-N 5-chloro-1,3-dihydroindol-2-one Chemical compound ClC1=CC=C2NC(=O)CC2=C1 WWJLCYHYLZZXBE-UHFFFAOYSA-N 0.000 description 3
- OALYTRUKMRCXNH-UHFFFAOYSA-N 5-pentyloxolan-2-one Chemical compound CCCCCC1CCC(=O)O1 OALYTRUKMRCXNH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KGEKLUUHTZCSIP-UHFFFAOYSA-N Isobornyl acetate Natural products C1CC2(C)C(OC(=O)C)CC1C2(C)C KGEKLUUHTZCSIP-UHFFFAOYSA-N 0.000 description 3
- 240000003183 Manihot esculenta Species 0.000 description 3
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- 239000001940 [(1R,4S,6R)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Substances 0.000 description 3
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 3
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 3
- UZFLPKAIBPNNCA-UHFFFAOYSA-N alpha-ionone Natural products CC(=O)C=CC1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-UHFFFAOYSA-N 0.000 description 3
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 3
- YPZUZOLGGMJZJO-LQKXBSAESA-N ambroxan Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)[C@@H]1[C@]2(C)OCC1 YPZUZOLGGMJZJO-LQKXBSAESA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229940073505 ethyl vanillin Drugs 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229940102398 methyl anthranilate Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 230000001012 protector Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 235000007586 terpenes Nutrition 0.000 description 3
- KMPQYAYAQWNLME-UHFFFAOYSA-N undecanal Chemical compound CCCCCCCCCCC=O KMPQYAYAQWNLME-UHFFFAOYSA-N 0.000 description 3
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 2
- ULDHMXUKGWMISQ-VIFPVBQESA-N (+)-carvone Chemical compound CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- 229940098795 (3z)- 3-hexenyl acetate Drugs 0.000 description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 2
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 2
- KHQDWCKZXLWDNM-KPKJPENVSA-N (e)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol Chemical compound CC\C(CO)=C/CC1CC=C(C)C1(C)C KHQDWCKZXLWDNM-KPKJPENVSA-N 0.000 description 2
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 description 2
- RNLHVODSMDJCBR-VURMDHGXSA-N (z)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol Chemical compound CC(O)C(C)\C=C/C1CC=C(C)C1(C)C RNLHVODSMDJCBR-VURMDHGXSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- MVOSYKNQRRHGKX-UHFFFAOYSA-N 11-Undecanolactone Chemical compound O=C1CCCCCCCCCCO1 MVOSYKNQRRHGKX-UHFFFAOYSA-N 0.000 description 2
- ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 2-octanone Chemical compound CCCCCCC(C)=O ZPVFWPFBNIEHGJ-UHFFFAOYSA-N 0.000 description 2
- ZHDQGHCZWWDMRS-UHFFFAOYSA-N 3,5-dimethylcyclohex-3-ene-1-carbaldehyde Chemical compound CC1CC(C=O)CC(C)=C1 ZHDQGHCZWWDMRS-UHFFFAOYSA-N 0.000 description 2
- PRNCMAKCNVRZFX-UHFFFAOYSA-N 3,7-dimethyloctan-1-ol Chemical compound CC(C)CCCC(C)CCO PRNCMAKCNVRZFX-UHFFFAOYSA-N 0.000 description 2
- OXYRENDGHPGWKV-UHFFFAOYSA-N 3-methyl-5-phenylpentan-1-ol Chemical compound OCCC(C)CCC1=CC=CC=C1 OXYRENDGHPGWKV-UHFFFAOYSA-N 0.000 description 2
- RHLVCLIPMVJYKS-UHFFFAOYSA-N 3-octanone Chemical compound CCCCCC(=O)CC RHLVCLIPMVJYKS-UHFFFAOYSA-N 0.000 description 2
- ORMHZBNNECIKOH-UHFFFAOYSA-N 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde Chemical compound CC(C)(O)CCCC1=CCC(C=O)CC1 ORMHZBNNECIKOH-UHFFFAOYSA-N 0.000 description 2
- NTPLXRHDUXRPNE-UHFFFAOYSA-N 4-methoxyacetophenone Chemical compound COC1=CC=C(C(C)=O)C=C1 NTPLXRHDUXRPNE-UHFFFAOYSA-N 0.000 description 2
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 description 2
- LJSJTXAZFHYHMM-UHFFFAOYSA-N 7-methyloctyl acetate Chemical compound CC(C)CCCCCCOC(C)=O LJSJTXAZFHYHMM-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HVJKZICIMIWFCP-UHFFFAOYSA-N Benzyl 3-methylbutanoate Chemical compound CC(C)CC(=O)OCC1=CC=CC=C1 HVJKZICIMIWFCP-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N Benzylformate Chemical compound O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 2
- 244000166675 Cymbopogon nardus Species 0.000 description 2
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 2
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 2
- RFDUMBPGZUIKOG-UHFFFAOYSA-N Heptyl 2-methylpropanoate Chemical compound CCCCCCCOC(=O)C(C)C RFDUMBPGZUIKOG-UHFFFAOYSA-N 0.000 description 2
- CYHBDKTZDLSRMY-UHFFFAOYSA-N Hexyl 2-methylpropanoate Chemical compound CCCCCCOC(=O)C(C)C CYHBDKTZDLSRMY-UHFFFAOYSA-N 0.000 description 2
- RSDDTPVXLMVLQE-UHFFFAOYSA-N Hexyl 3-methylbutanoate Chemical compound CCCCCCOC(=O)CC(C)C RSDDTPVXLMVLQE-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 description 2
- FHLGUOHLUFIAAA-UHFFFAOYSA-N Linalyl butyrate Chemical compound CCCC(=O)OC(C)(C=C)CCC=C(C)C FHLGUOHLUFIAAA-UHFFFAOYSA-N 0.000 description 2
- JZIARAQCPRDGAC-UHFFFAOYSA-N Linalyl isobutyrate Chemical compound CC(C)C(=O)OC(C)(C=C)CCC=C(C)C JZIARAQCPRDGAC-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 2
- IYTXKIXETAELAV-UHFFFAOYSA-N Nonan-3-one Chemical compound CCCCCCC(=O)CC IYTXKIXETAELAV-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 2
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 2
- 229940088601 alpha-terpineol Drugs 0.000 description 2
- 229940011037 anethole Drugs 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 210000000040 apocrine gland Anatomy 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 2
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- XSIFPSYPOVKYCO-UHFFFAOYSA-N butyl benzoate Chemical compound CCCCOC(=O)C1=CC=CC=C1 XSIFPSYPOVKYCO-UHFFFAOYSA-N 0.000 description 2
- RPRPDTXKGSIXMD-UHFFFAOYSA-N butyl hexanoate Chemical compound CCCCCC(=O)OCCCC RPRPDTXKGSIXMD-UHFFFAOYSA-N 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- NPFVOOAXDOBMCE-PLNGDYQASA-N cis-3-Hexenyl acetate Natural products CC\C=C/CCOC(C)=O NPFVOOAXDOBMCE-PLNGDYQASA-N 0.000 description 2
- RRGOKSYVAZDNKR-ARJAWSKDSA-M cis-3-hexenylacetate Chemical compound CC\C=C/CCCC([O-])=O RRGOKSYVAZDNKR-ARJAWSKDSA-M 0.000 description 2
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
- 235000000484 citronellol Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- ZAJNGDIORYACQU-UHFFFAOYSA-N decan-2-one Chemical compound CCCCCCCCC(C)=O ZAJNGDIORYACQU-UHFFFAOYSA-N 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 210000000804 eccrine gland Anatomy 0.000 description 2
- HCRBXQFHJMCTLF-ZCFIWIBFSA-N ethyl (2r)-2-methylbutanoate Chemical compound CCOC(=O)[C@H](C)CC HCRBXQFHJMCTLF-ZCFIWIBFSA-N 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 2
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 2
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- HYNGAVZPWWXQIU-UHFFFAOYSA-N lavandulyl acetate Chemical compound CC(C)=CCC(C(C)=C)COC(C)=O HYNGAVZPWWXQIU-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- OVGXLJDWSLQDRT-CEOVSRFSSA-L magnesium;(2s)-2-hydroxypropanoate Chemical compound [Mg+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O OVGXLJDWSLQDRT-CEOVSRFSSA-L 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- GVOWHGSUZUUUDR-UHFFFAOYSA-N methyl N-methylanthranilate Chemical compound CNC1=CC=CC=C1C(=O)OC GVOWHGSUZUUUDR-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- VKCYHJWLYTUGCC-UHFFFAOYSA-N nonan-2-one Chemical compound CCCCCCCC(C)=O VKCYHJWLYTUGCC-UHFFFAOYSA-N 0.000 description 2
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- GJQIMXVRFNLMTB-UHFFFAOYSA-N nonyl acetate Chemical compound CCCCCCCCCOC(C)=O GJQIMXVRFNLMTB-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 229940100595 phenylacetaldehyde Drugs 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N propiophenone Chemical compound CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 2
- 229940100486 rice starch Drugs 0.000 description 2
- CZCBTSFUTPZVKJ-UHFFFAOYSA-N rose oxide Chemical compound CC1CCOC(C=C(C)C)C1 CZCBTSFUTPZVKJ-UHFFFAOYSA-N 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000008786 sensory perception of smell Effects 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 229940116411 terpineol Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- NPFVOOAXDOBMCE-UHFFFAOYSA-N trans-3-hexenyl acetate Natural products CCC=CCCOC(C)=O NPFVOOAXDOBMCE-UHFFFAOYSA-N 0.000 description 2
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical compound CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- PHXATPHONSXBIL-UHFFFAOYSA-N xi-gamma-Undecalactone Chemical compound CCCCCCCC1CCC(=O)O1 PHXATPHONSXBIL-UHFFFAOYSA-N 0.000 description 2
- 229960001296 zinc oxide Drugs 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- 229930007850 β-damascenone Natural products 0.000 description 2
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- ULDHMXUKGWMISQ-SECBINFHSA-N (-)-carvone Chemical compound CC(=C)[C@@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-SECBINFHSA-N 0.000 description 1
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- NOOLISFMXDJSKH-LPEHRKFASA-N (1r,2s,5s)-5-methyl-2-propan-2-ylcyclohexan-1-ol Chemical compound CC(C)[C@@H]1CC[C@H](C)C[C@H]1O NOOLISFMXDJSKH-LPEHRKFASA-N 0.000 description 1
- FINOAUDUYKVGDS-UHFFFAOYSA-N (2-tert-butylcyclohexyl) acetate Chemical compound CC(=O)OC1CCCCC1C(C)(C)C FINOAUDUYKVGDS-UHFFFAOYSA-N 0.000 description 1
- HLCSDJLATUNSSI-JXMROGBWSA-N (2e)-3,7-dimethylocta-2,6-dienenitrile Chemical compound CC(C)=CCC\C(C)=C\C#N HLCSDJLATUNSSI-JXMROGBWSA-N 0.000 description 1
- ZIIKTNCFALFPNK-UHFFFAOYSA-N (4-tert-butylcyclohexyl) formate Chemical compound CC(C)(C)C1CCC(OC=O)CC1 ZIIKTNCFALFPNK-UHFFFAOYSA-N 0.000 description 1
- GQVMHMFBVWSSPF-SOYUKNQTSA-N (4E,6E)-2,6-dimethylocta-2,4,6-triene Chemical compound C\C=C(/C)\C=C\C=C(C)C GQVMHMFBVWSSPF-SOYUKNQTSA-N 0.000 description 1
- 239000001303 (5-methyl-2-prop-1-en-2-ylcyclohexyl) acetate Substances 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- 239000001674 (E)-1-(2,6,6-trimethyl-1-cyclohexenyl)but-2-en-1-one Substances 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- JLIDRDJNLAWIKT-UHFFFAOYSA-N 1,2-dimethyl-3h-benzo[e]indole Chemical compound C1=CC=CC2=C(C(=C(C)N3)C)C3=CC=C21 JLIDRDJNLAWIKT-UHFFFAOYSA-N 0.000 description 1
- BGTBFNDXYDYBEY-UHFFFAOYSA-N 1-(2,6,6-trimethylcyclohexen-1-yl)but-2-en-1-one Chemical compound CC=CC(=O)C1=C(C)CCCC1(C)C BGTBFNDXYDYBEY-UHFFFAOYSA-N 0.000 description 1
- CHLICZRVGGXEOD-UHFFFAOYSA-N 1-Methoxy-4-methylbenzene Chemical compound COC1=CC=C(C)C=C1 CHLICZRVGGXEOD-UHFFFAOYSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- BFNMZJQMWPPBKE-UHFFFAOYSA-N 1-oxo-3h-2-benzofuran-4-carbonitrile Chemical compound C1=CC=C(C#N)C2=C1C(=O)OC2 BFNMZJQMWPPBKE-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- MZZRKEIUNOYYDF-UHFFFAOYSA-N 2,4-dimethylcyclohex-3-ene-1-carbaldehyde Chemical compound CC1C=C(C)CCC1C=O MZZRKEIUNOYYDF-UHFFFAOYSA-N 0.000 description 1
- BEARMGATPGLSKG-UHFFFAOYSA-N 2,6-dimethyloct-7-en-2-yl acetate Chemical compound C=CC(C)CCCC(C)(C)OC(C)=O BEARMGATPGLSKG-UHFFFAOYSA-N 0.000 description 1
- VVUMWAHNKOLVSN-UHFFFAOYSA-N 2-(4-ethoxyanilino)-n-propylpropanamide Chemical compound CCCNC(=O)C(C)NC1=CC=C(OCC)C=C1 VVUMWAHNKOLVSN-UHFFFAOYSA-N 0.000 description 1
- 239000001952 2-(4-methyl-1-cyclohex-3-enyl)propan-2-yl propanoate Substances 0.000 description 1
- GXXXUZIRGXYDFP-UHFFFAOYSA-M 2-(4-methylphenyl)acetate Chemical compound CC1=CC=C(CC([O-])=O)C=C1 GXXXUZIRGXYDFP-UHFFFAOYSA-M 0.000 description 1
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Substances 0.000 description 1
- WNAJXPYVTFYEST-UHFFFAOYSA-N 2-Amino-3-methylbenzoate Chemical compound CC1=CC=CC(C(O)=O)=C1N WNAJXPYVTFYEST-UHFFFAOYSA-N 0.000 description 1
- LUZDYPLAQQGJEA-UHFFFAOYSA-N 2-Methoxynaphthalene Chemical compound C1=CC=CC2=CC(OC)=CC=C21 LUZDYPLAQQGJEA-UHFFFAOYSA-N 0.000 description 1
- FLUWAIIVLCVEKF-UHFFFAOYSA-N 2-Methyl-1-phenyl-2-propanyl acetate Chemical compound CC(=O)OC(C)(C)CC1=CC=CC=C1 FLUWAIIVLCVEKF-UHFFFAOYSA-N 0.000 description 1
- RNDNSYIPLPAXAZ-UHFFFAOYSA-N 2-Phenyl-1-propanol Chemical compound OCC(C)C1=CC=CC=C1 RNDNSYIPLPAXAZ-UHFFFAOYSA-N 0.000 description 1
- PXWNBAGCFUDYBE-UHFFFAOYSA-N 2-Phenylethyl 2-aminobenzoate Chemical compound NC1=CC=CC=C1C(=O)OCCC1=CC=CC=C1 PXWNBAGCFUDYBE-UHFFFAOYSA-N 0.000 description 1
- SJWKGDGUQTWDRV-UHFFFAOYSA-N 2-Propenyl heptanoate Chemical compound CCCCCCC(=O)OCC=C SJWKGDGUQTWDRV-UHFFFAOYSA-N 0.000 description 1
- RCSBILYQLVXLJG-UHFFFAOYSA-N 2-Propenyl hexanoate Chemical compound CCCCCC(=O)OCC=C RCSBILYQLVXLJG-UHFFFAOYSA-N 0.000 description 1
- QGLVWTFUWVTDEQ-UHFFFAOYSA-N 2-chloro-3-methoxyphenol Chemical compound COC1=CC=CC(O)=C1Cl QGLVWTFUWVTDEQ-UHFFFAOYSA-N 0.000 description 1
- DVCHJFSLGUNEQZ-UHFFFAOYSA-M 2-ethenyl-2,6-dimethylhept-5-enoate Chemical compound CC(C)=CCCC(C)(C=C)C([O-])=O DVCHJFSLGUNEQZ-UHFFFAOYSA-M 0.000 description 1
- ZCHHRLHTBGRGOT-UHFFFAOYSA-N 2-hexen-1-ol Chemical compound CCCC=CCO ZCHHRLHTBGRGOT-UHFFFAOYSA-N 0.000 description 1
- YRNDGUSDBCARGC-UHFFFAOYSA-N 2-methoxyacetophenone Chemical compound COCC(=O)C1=CC=CC=C1 YRNDGUSDBCARGC-UHFFFAOYSA-N 0.000 description 1
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- FWZVJHOHQPCKQQ-UHFFFAOYSA-N 2-methyl-2-(2-methylprop-1-enyl)oxane Chemical compound CC(C)=CC1(C)CCCCO1 FWZVJHOHQPCKQQ-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- LBICMZLDYMBIGA-UHFFFAOYSA-N 2-methyldecanal Chemical compound CCCCCCCCC(C)C=O LBICMZLDYMBIGA-UHFFFAOYSA-N 0.000 description 1
- NFAVNWJJYQAGNB-UHFFFAOYSA-N 2-methylundecanal Chemical compound CCCCCCCCCC(C)C=O NFAVNWJJYQAGNB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- GNTQOKGIVMJHQG-UHFFFAOYSA-N 2-propan-2-yloxypyridine-3-carbaldehyde Chemical compound CC(C)OC1=NC=CC=C1C=O GNTQOKGIVMJHQG-UHFFFAOYSA-N 0.000 description 1
- PANBRUWVURLWGY-UHFFFAOYSA-N 2-undecenal Chemical compound CCCCCCCCC=CC=O PANBRUWVURLWGY-UHFFFAOYSA-N 0.000 description 1
- DLHQZZUEERVIGQ-UHFFFAOYSA-N 3,7-dimethyl-3-octanol Chemical compound CCC(C)(O)CCCC(C)C DLHQZZUEERVIGQ-UHFFFAOYSA-N 0.000 description 1
- MTDAKBBUYMYKAR-UHFFFAOYSA-N 3,7-dimethyloct-6-enenitrile Chemical compound N#CCC(C)CCC=C(C)C MTDAKBBUYMYKAR-UHFFFAOYSA-N 0.000 description 1
- UCSIFMPORANABL-UHFFFAOYSA-N 3,7-dimethyloctanal Chemical compound CC(C)CCCC(C)CC=O UCSIFMPORANABL-UHFFFAOYSA-N 0.000 description 1
- JRJBVWJSTHECJK-PKNBQFBNSA-N 3-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one Chemical compound CC(=O)C(\C)=C\C1C(C)=CCCC1(C)C JRJBVWJSTHECJK-PKNBQFBNSA-N 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- 239000001623 3-phenylprop-2-enyl formate Substances 0.000 description 1
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 description 1
- WDTVJRYCMIZPMX-UHFFFAOYSA-N 4-chloro-2-methylpyrimidine Chemical compound CC1=NC=CC(Cl)=N1 WDTVJRYCMIZPMX-UHFFFAOYSA-N 0.000 description 1
- OIGWAXDAPKFNCQ-UHFFFAOYSA-N 4-isopropylbenzyl alcohol Chemical compound CC(C)C1=CC=C(CO)C=C1 OIGWAXDAPKFNCQ-UHFFFAOYSA-N 0.000 description 1
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- MBZRJSQZCBXRGK-UHFFFAOYSA-N 4-tert-Butylcyclohexyl acetate Chemical compound CC(=O)OC1CCC(C(C)(C)C)CC1 MBZRJSQZCBXRGK-UHFFFAOYSA-N 0.000 description 1
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
- RMCHMXPTUMFFBZ-UHFFFAOYSA-N 5-bromo-1-methylindazole Chemical compound BrC1=CC=C2N(C)N=CC2=C1 RMCHMXPTUMFFBZ-UHFFFAOYSA-N 0.000 description 1
- YZRXRLLRSPQHDK-UHFFFAOYSA-N 6-Hexyltetrahydro-2H-pyran-2-one Chemical compound CCCCCCC1CCCC(=O)O1 YZRXRLLRSPQHDK-UHFFFAOYSA-N 0.000 description 1
- AUBLFWWZTFFBNU-UHFFFAOYSA-N 6-butan-2-ylquinoline Chemical compound N1=CC=CC2=CC(C(C)CC)=CC=C21 AUBLFWWZTFFBNU-UHFFFAOYSA-N 0.000 description 1
- QDTDKYHPHANITQ-UHFFFAOYSA-N 7-methyloctan-1-ol Chemical compound CC(C)CCCCCCO QDTDKYHPHANITQ-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 238000006677 Appel reaction Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- BAVONGHXFVOKBV-UHFFFAOYSA-N Carveol Chemical compound CC(=C)C1CC=C(C)C(O)C1 BAVONGHXFVOKBV-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- ZGPPERKMXSGYRK-UHFFFAOYSA-N Citronellyl isobutyrate Chemical compound CC(C)=CCCC(C)CCOC(=O)C(C)C ZGPPERKMXSGYRK-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- TWLLPUMZVVGILS-UHFFFAOYSA-N Ethyl 2-aminobenzoate Chemical compound CCOC(=O)C1=CC=CC=C1N TWLLPUMZVVGILS-UHFFFAOYSA-N 0.000 description 1
- KBEBGUQPQBELIU-CMDGGOBGSA-N Ethyl cinnamate Chemical compound CCOC(=O)\C=C\C1=CC=CC=C1 KBEBGUQPQBELIU-CMDGGOBGSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- OUGPMNMLWKSBRI-UHFFFAOYSA-N Hexyl formate Chemical compound CCCCCCOC=O OUGPMNMLWKSBRI-UHFFFAOYSA-N 0.000 description 1
- 239000004439 Isononyl alcohol Substances 0.000 description 1
- HLHIVJRLODSUCI-ADEWGFFLSA-N Isopulegol acetate Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](OC(C)=O)C1 HLHIVJRLODSUCI-ADEWGFFLSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- BRHDDEIRQPDPMG-UHFFFAOYSA-N Linalyl oxide Chemical compound CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 description 1
- JBVVONYMRFACPQ-UHFFFAOYSA-N Linalylformate Natural products CC(=C)CCCC(C)(OC=O)C=C JBVVONYMRFACPQ-UHFFFAOYSA-N 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 239000006001 Methyl nonyl ketone Substances 0.000 description 1
- VKEQBMCRQDSRET-UHFFFAOYSA-N Methylone Chemical compound CNC(C)C(=O)C1=CC=C2OCOC2=C1 VKEQBMCRQDSRET-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- FTXUQEKXCJSWMO-UHFFFAOYSA-N Nonanolactone Chemical compound O=C1CCCCCCCCO1 FTXUQEKXCJSWMO-UHFFFAOYSA-N 0.000 description 1
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical group COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241001364096 Pachycephalidae Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- VONGZNXBKCOUHB-UHFFFAOYSA-N Phenylmethyl butanoate Chemical compound CCCC(=O)OCC1=CC=CC=C1 VONGZNXBKCOUHB-UHFFFAOYSA-N 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- POPNTVRHTZDEBW-UHFFFAOYSA-N Propionsaeure-citronellylester Natural products CCC(=O)OCCC(C)CCC=C(C)C POPNTVRHTZDEBW-UHFFFAOYSA-N 0.000 description 1
- BYCHQEILESTMQU-UHFFFAOYSA-N Propionsaeure-nerylester Natural products CCC(=O)OCC=C(C)CCC=C(C)C BYCHQEILESTMQU-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010066218 Stress Urinary Incontinence Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- FAFMZORPAAGQFV-BREBYQMCSA-N [(1r,3r,4r)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] propanoate Chemical compound C1C[C@@]2(C)[C@H](OC(=O)CC)C[C@@H]1C2(C)C FAFMZORPAAGQFV-BREBYQMCSA-N 0.000 description 1
- LMETVDMCIJNNKH-UHFFFAOYSA-N [(3,7-Dimethyl-6-octenyl)oxy]acetaldehyde Chemical compound CC(C)=CCCC(C)CCOCC=O LMETVDMCIJNNKH-UHFFFAOYSA-N 0.000 description 1
- WUEJOVNIQISNHV-BQYQJAHWSA-N [(E)-hex-1-enyl] 2-methylpropanoate Chemical compound CCCC\C=C\OC(=O)C(C)C WUEJOVNIQISNHV-BQYQJAHWSA-N 0.000 description 1
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
- MGQIWUQTCOJGJU-UHFFFAOYSA-N [AlH3].Cl Chemical compound [AlH3].Cl MGQIWUQTCOJGJU-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- ZCZSIDMEHXZRLG-UHFFFAOYSA-N acetic acid heptyl ester Natural products CCCCCCCOC(C)=O ZCZSIDMEHXZRLG-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- CMKQOKAXUWQAHG-UHFFFAOYSA-N alpha-Terpineol propanoate Chemical compound CCC(=O)OC(C)(C)C1CCC(C)=CC1 CMKQOKAXUWQAHG-UHFFFAOYSA-N 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 238000000498 ball milling Methods 0.000 description 1
- DULCUDSUACXJJC-UHFFFAOYSA-N benzeneacetic acid ethyl ester Natural products CCOC(=O)CC1=CC=CC=C1 DULCUDSUACXJJC-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 210000003103 bodily secretion Anatomy 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- HUIYGGQINIVDNW-UHFFFAOYSA-N butyl anthranilate Chemical compound CCCCOC(=O)C1=CC=CC=C1N HUIYGGQINIVDNW-UHFFFAOYSA-N 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 description 1
- 229940026455 cedrol Drugs 0.000 description 1
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- AQIXAKUUQRKLND-UHFFFAOYSA-N cimetidine Chemical compound N#C/N=C(/NC)NCCSCC=1N=CNC=1C AQIXAKUUQRKLND-UHFFFAOYSA-N 0.000 description 1
- KBEBGUQPQBELIU-UHFFFAOYSA-N cinnamic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=CC=C1 KBEBGUQPQBELIU-UHFFFAOYSA-N 0.000 description 1
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 1
- RGACQXBDYBCJCY-ALCCZGGFSA-N cis-3-Hexenyl hexanoate Chemical compound CCCCCC(=O)OCC\C=C/CC RGACQXBDYBCJCY-ALCCZGGFSA-N 0.000 description 1
- ZCHOPXVYTWUHDS-UHFFFAOYSA-N cis-3-hexenyl n-butyrate Natural products CCCC(=O)OCCC=CCC ZCHOPXVYTWUHDS-UHFFFAOYSA-N 0.000 description 1
- GQVMHMFBVWSSPF-UHFFFAOYSA-N cis-alloocimene Natural products CC=C(C)C=CC=C(C)C GQVMHMFBVWSSPF-UHFFFAOYSA-N 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- WTWBUQJHJGUZCY-UHFFFAOYSA-N cuminaldehyde Chemical compound CC(C)C1=CC=C(C=O)C=C1 WTWBUQJHJGUZCY-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 1
- NAUHBXFHKWSIPS-UHFFFAOYSA-H dialuminum;butanedioate Chemical compound [Al+3].[Al+3].[O-]C(=O)CCC([O-])=O.[O-]C(=O)CCC([O-])=O.[O-]C(=O)CCC([O-])=O NAUHBXFHKWSIPS-UHFFFAOYSA-H 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940095104 dimethyl benzyl carbinyl acetate Drugs 0.000 description 1
- 125000006182 dimethyl benzyl group Chemical group 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical compound O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000001813 ethyl (2R)-2-methylbutanoate Substances 0.000 description 1
- XWEOGMYZFCHQNT-UHFFFAOYSA-N ethyl 2-(2-methyl-1,3-dioxolan-2-yl)acetate Chemical compound CCOC(=O)CC1(C)OCCO1 XWEOGMYZFCHQNT-UHFFFAOYSA-N 0.000 description 1
- 229940090910 ethyl 2-methylbutyrate Drugs 0.000 description 1
- YUIDGONLMDUWNF-UHFFFAOYSA-N ethyl 3-chloro-4h-thieno[3,2-b]pyrrole-5-carboxylate Chemical compound S1C=C(Cl)C2=C1C=C(C(=O)OCC)N2 YUIDGONLMDUWNF-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- OALYTRUKMRCXNH-QMMMGPOBSA-N gamma-Nonalactone Natural products CCCCC[C@H]1CCC(=O)O1 OALYTRUKMRCXNH-QMMMGPOBSA-N 0.000 description 1
- PHXATPHONSXBIL-JTQLQIEISA-N gamma-Undecalactone Natural products CCCCCCC[C@H]1CCC(=O)O1 PHXATPHONSXBIL-JTQLQIEISA-N 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 229930007090 gamma-ionone Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940020436 gamma-undecalactone Drugs 0.000 description 1
- FQMZVFJYMPNUCT-UHFFFAOYSA-N geraniol formate Natural products CC(C)=CCCC(C)=CCOC=O FQMZVFJYMPNUCT-UHFFFAOYSA-N 0.000 description 1
- RYILZWKGLGVPOC-XYOKQWHBSA-N geranyl acetoacetate Chemical compound CC(=O)CC(=O)OC\C=C(/C)CCC=C(C)C RYILZWKGLGVPOC-XYOKQWHBSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003621 hammer milling Methods 0.000 description 1
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 1
- JPXGPRBLTIYFQG-UHFFFAOYSA-N heptan-4-yl acetate Chemical compound CCCC(CCC)OC(C)=O JPXGPRBLTIYFQG-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- BGYICJVBGZQOCY-UHFFFAOYSA-N heptyl propanoate Chemical compound CCCCCCCOC(=O)CC BGYICJVBGZQOCY-UHFFFAOYSA-N 0.000 description 1
- YDZCHDQXPLJVBG-UHFFFAOYSA-N hex-1-enyl acetate Chemical compound CCCCC=COC(C)=O YDZCHDQXPLJVBG-UHFFFAOYSA-N 0.000 description 1
- RQSINLZXJXXKOH-UHFFFAOYSA-N hexyl 2,2-dimethylpropanoate Chemical compound CCCCCCOC(=O)C(C)(C)C RQSINLZXJXXKOH-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 description 1
- 201000010759 hypertrophy of breast Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- DIICMQCJAQLQPI-UHFFFAOYSA-N isobornyl propionate Natural products CCC(=O)C1CC2CCC1(C)C2(C)C DIICMQCJAQLQPI-UHFFFAOYSA-N 0.000 description 1
- UXUPPWPIGVTVQI-UHFFFAOYSA-N isobutyl hexanoate Chemical compound CCCCCC(=O)OCC(C)C UXUPPWPIGVTVQI-UHFFFAOYSA-N 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Natural products CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- PICNSXCJRMYANX-UHFFFAOYSA-N methyl 2-chloro-4-nitrobenzoate Chemical compound COC(=O)C1=CC=C([N+]([O-])=O)C=C1Cl PICNSXCJRMYANX-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 1
- 229940115425 methylbenzyl acetate Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- FALTVGCCGMDSNZ-UHFFFAOYSA-N n-(1-phenylethyl)benzamide Chemical compound C=1C=CC=CC=1C(C)NC(=O)C1=CC=CC=C1 FALTVGCCGMDSNZ-UHFFFAOYSA-N 0.000 description 1
- ZYTMANIQRDEHIO-UHFFFAOYSA-N neo-Isopulegol Natural products CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- RVNCBAPCNVAWOY-UHFFFAOYSA-N nonyl butyrate Chemical compound CCCCCCCCCOC(=O)CCC RVNCBAPCNVAWOY-UHFFFAOYSA-N 0.000 description 1
- BOPPSUHPZARXTH-UHFFFAOYSA-N ocean propanal Chemical compound O=CC(C)CC1=CC=C2OCOC2=C1 BOPPSUHPZARXTH-UHFFFAOYSA-N 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N p-methylphenyl methyl ketone Natural products CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- QKNZNUNCDJZTCH-UHFFFAOYSA-N pentyl benzoate Chemical compound CCCCCOC(=O)C1=CC=CC=C1 QKNZNUNCDJZTCH-UHFFFAOYSA-N 0.000 description 1
- TWSRVQVEYJNFKQ-UHFFFAOYSA-N pentyl propanoate Chemical compound CCCCCOC(=O)CC TWSRVQVEYJNFKQ-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- WFNDDSQUKATKNX-UHFFFAOYSA-N phenethyl butyrate Chemical compound CCCC(=O)OCCC1=CC=CC=C1 WFNDDSQUKATKNX-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-M phenylacetate Chemical compound [O-]C(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-M 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940098458 powder spray Drugs 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- HUAZGNHGCJGYNP-UHFFFAOYSA-N propyl butyrate Chemical compound CCCOC(=O)CCC HUAZGNHGCJGYNP-UHFFFAOYSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930007790 rose oxide Natural products 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229910021487 silica fume Inorganic materials 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- 229940076133 sodium carbonate monohydrate Drugs 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- KWVISVAMQJWJSZ-VKROHFNGSA-N solasodine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CN1 KWVISVAMQJWJSZ-VKROHFNGSA-N 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- VSRBKQFNFZQRBM-UHFFFAOYSA-N tuaminoheptane Chemical compound CCCCCC(C)N VSRBKQFNFZQRBM-UHFFFAOYSA-N 0.000 description 1
- 229960003986 tuaminoheptane Drugs 0.000 description 1
- GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 1
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 1
- 229940057402 undecyl alcohol Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 description 1
- YEIGUXGHHKAURB-VAMGGRTRSA-N viridin Chemical compound O=C1C2=C3CCC(=O)C3=CC=C2[C@@]2(C)[C@H](O)[C@H](OC)C(=O)C3=COC1=C23 YEIGUXGHHKAURB-VAMGGRTRSA-N 0.000 description 1
- 108010086097 viridin Proteins 0.000 description 1
- YEIGUXGHHKAURB-UHFFFAOYSA-N viridine Natural products O=C1C2=C3CCC(=O)C3=CC=C2C2(C)C(O)C(OC)C(=O)C3=COC1=C23 YEIGUXGHHKAURB-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 1
- 229940100530 zinc ricinoleate Drugs 0.000 description 1
- 229940118257 zinc undecylenate Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- IHPKGUQCSIINRJ-UHFFFAOYSA-N β-ocimene Natural products CC(C)=CCC=C(C)C=C IHPKGUQCSIINRJ-UHFFFAOYSA-N 0.000 description 1
- SFEOKXHPFMOVRM-BQYQJAHWSA-N γ-ionone Chemical compound CC(=O)\C=C\C1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-BQYQJAHWSA-N 0.000 description 1
Abstract
La presente invención se refiere a una composición en polvo perfumada absorbente de olores y opcionalmente de humedad, la cual es segura para usarse sobre la piel y comprende aproximadamente 0.1%a aproximadamente 25%, en peso de la composición, de ciclodextrina no complejada;alrededor de 5%a aproximadamente 601%, en peso de la composición, de un absorbente de humedad altamente efectivo;una composición de perfume seleccionada del grupo que consiste de aproximadamente 0.050%a aproximadamente 15%, en peso de la composición absorbente de olores, de un perfume encapsulado, y alrededor de 0.01%a aproximadamente 5%en peso de la composición absorbente de olores, de un perfume en forma libre, y mezclas de los mismos, y de un vehículo en polvo;las composiciones de lapresente invención también pueden contener un agente de control de olores adicional seleccionado del grupo que consiste de zeolita, carbón activado, bicarbonato de sodio, agentes antimicrobianos y antitranspirantes.
Description
PERFUMED COMPOSITIONS? METHODS TO REDUCE ODORS AND EXCESS OF MOISTURE IN THE BODY
BACKGROUND OF THE INVENTION
Body odor is commonly caused by fatty acids in the skin and bad odors from microbial sources. Human skin is naturally populated by numerous microorganisms that are fed by vain substances secreted by the skin (sweat by eccrine and apocrine glands and sebum), skin cell waste, skin breakdown products and by the organisms themselves. These unpleasant body odors are mainly organic molecules having different structures and functional groups, such as amines, acids, alcohols, aldehydes, ketones, phenolics, polycyclics, indoles, aromatics, polyaromatics, and so on. They may also be made of functional groups containing sulfur, such as thiol, mercaptan, sulfur and / or disulfide groups. Numerous attempts have been made to control or absorb coforal odors. Attempts have been made to strip microbes responsible for body odor from the humid environment they need to proliferate and grow. Such attempts include the use of powders and / or antiperspirants. Powders for the body and powder-based compositions of the prior art have limited absorption capacities. Antiperspirants are not always preferred in a product to control body odor, because if they are used throughout the body they can interfere with the body thermal regulatory procedure by inhibiting perspiration through the action of astringent salts. Additionally, such salts can be irritating to a large number of users, particularly, when applied in sensitive areas such as the pelvic region. Other deodorant compositions that are used to combat / control odor associated with skin secretions, which are described in the chemical and cosmetic literature, include emulsion sticks or suspension bars, aerosols, roll-ons (ball applicators), pads , atomizers, and even soap bars. These known deodorants try to control the odor through a variety of means. For example, the Patent of E.U.A. No. 5,525,331, to Betts, issued June 11, 1996, discloses compositions that inhibit the growth of microorganisms in bodily secretions. Deodorants can also include antibacterial compounds that help destroy / control the amount of bacteria present in the skin, minimizing the odor produced by the bacterial metabolism of skin secretions. The zeolites are known odor absorbers. However, these solid odor absorbers, in addition to known activated carbon odor absorbers, lose functionality when moistened. Therefore, when moistened by body fluids or when made in an aqueous solution, these odor absorbers are not preferred as they lose their desired odor absorbing characteristics. In addition, zeolites can cause "rough" sensation if too many are deposited on the skin. In addition to the aforementioned attempts to control and / or absorb body odors, several attempts have been made to mask body odors with other scents or perfumes. However, perfumes are often unsuitable for mitigating body odors and can be irritating to the user when used alone to control odor. Thus, there is a need for an improved, perfumed composition for absorbing odors and moisture and methods for their use, which is essentially free of irritant and astringent antiperspirants and which is safe and effective for use throughout the body. Particularly, there is a need to obtain a composition that remains on the skin and is capable of absorbing a broad spectrum of body odors and excess moisture that are not completely extinguished by the aforementioned means. It has been discovered that said improved body odor control and optionally moisture control can be provided to the whole body by applying a composition, which remains on the skin, that incorporates cyclodextrins without forming complex odor absorbers.; highly effective moisture absorbing ingredients; perfume composition; and a powder vehicle. Surprisingly, it has been discovered that the perfume composition can be added without counteracting the body odor absorption utility of the cyclodextrins without complexing. A particular advantage of the present invention is the ability to provide convenient, non-irritating odor protection and optionally moisture protection when applied to concealed areas of skin such as the pelvic region, external vagina, the line of the panty, the line of the support, and folds of the skin, which can be very sensitive. In addition, it has been discovered that the aforementioned benefits can be provided in a powder vehicle that also optionally provides benefits on the user's skin such as protection and / or wetting. All percentages, ratios, and parts in the present invention, in the description, examples, and claims are by weight unless otherwise specified. The term "g", as used here, means gram. The term "my", as used here, means milliliter. The term "p", as used herein, means weight.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to a perfumed powdery odor and moisture absorbent composition, comprising about 0.1% to about 25%, by weight of the composition, of cyclodextrin without complexing; optionally, from about 5% to about 60%, by weight of the composition, of a highly effective moisture absorbent; a perfume composition selected from the group consisting of from about 0.5% to about 15%, by weight of the odor absorption composition, of an encapsulated perfume, and from about 0.01% to about 5% by weight of the absorbent composition of smell of a free perfume and mixtures thereof; and a powder vehicle. The compositions of the present invention may also contain an additional agent to control the odor selected from the group consisting of zeolites, activated carbon, sodium bicarbonate, antimicrobial agents and antiperspirants. The present invention also relates to methods of using the above compositions.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a perfumed dry powder composition useful for reducing body odor and moisture from hidden sites on the skin. The present invention also relates to an article of manufacture comprising the compositions herein deposited on flexible supply means. The composition of the present invention comprises dry ingredients preferably having particle sizes of from about 1 to about 100 microns; most preferably from about 1 miera to about 60 micras; and most preferably from about 1 miera to about 20 micras. As used herein, particle size refers to the largest dimension of the particle and the fundamental (or major) particles. The term "hidden skin", as used herein, refers to body regions of a human or mammal covered with clothing, such as
. s-. •%. iTMgu x srü the pelvic area, the line of the panties, and the bra line; and folds of the skin or intertriginous regions, where there is continuous skin-to-skin contact. The term "excess moisture", as used herein, means an undesirable and / or unhealthy level of bodily fluids deposited on the skin. The term "body fluids", as used herein, includes eccrine gland sweat, apocrine gland sweat, sebum, sensitive moisture accumulation from transepidermal water loss, vaginal discharge, urine, and mixtures thereof. The term "body odor" as used herein refers to odors that are generated as a result of the natural functioning of the body of a human or mammal. Such odors include, but are not limited to, odors produced by skin microorganisms (i.e., bacterial decomposition of skin secretions), urine or vaginal discharge, and mixtures thereof. The term "skin" refers to human or mammalian skin. The term "whole body" refers to the total external surface of human or mammalian skin. The term "vaginal odor" refers specifically to those body odors that emanate from the pelvic region of a woman, particularly the vagina and the line of the panties. A detailed description of the essential and optional components of the present invention follows.
CICLODEXTRIN As used in the present invention, the term "cyclodextrin" includes any of the known cyclodextrins such as unsubstituted cyclodextrins containing from 6 to 12 glucose units, especially alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and / or its derivatives and / or mixtures thereof. As used herein, the term "cyclodextrin without complexing" means that the cavities within the cyclodextrin in the composition of the present invention should remain essentially unfilled prior to application to the skin in order to allow the cyclodextrin to absorb several odor molecules when the composition is applied to the skin. Preferred cyclodextrins for use in the present invention are alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and / or its derivatives. Most preferred are beta-cyclodextrin, hydroxypropyl alpha-cyclodextrin, hydroxypropyl beta-cyclodextrin, methylated alpha-cyclodextrin or methylated beta-cyclodextrin. Most preferably beta-cyclodextrin. It is also preferable to use a mixture of cyclodextrins. Said mixtures absorb body odors extensively by complexing with a larger scale of odoriferous molecules having a larger scale of molecular sizes. The cyclodextrin levels are from about 0.1% to about 25%, preferably from about 1% to about 20%, most preferably from about 2% to about 15%, still most preferably from about 3% to about 10% , by weight of the composition. Complex formation between cyclodextrin and odorous molecules occurs rapidly when they are moistened with body fluids. 5 That is convenient for the user because the cyclodextrins, when they are on dry skin, will not fill their cavities with other environmental scents that would otherwise make them less efficient to absorb body odors. In particular, after the solubilization of cyclodextrin by body fluids, the isolated cavities are ready
to form inclusion complexes with body odor molecules. Therefore, the availability of cyclodextrin without forming solubilized complex is essential for effective and efficient odor control performance. Cyclodextrins that have small particle sizes help improve the surface availability of cyclodextrin to
odor absorption and therefore are preferable. As used herein, particle size refers to the largest dimension of the particle and the fundamental (or major) particles. The small particle size cyclodextrins of the invention are those having a particle size of less than about 12 microns, preferably less than 10 microns.
microns, and still very preferably less than 5 microns. A more complete description of cyclodextrins, cyclodextrin derivatives, and cyclodextrin particle sizes useful in the present invention can be found in
^^^^^^^^^^^^^^^^^^^^^^^^^^^ US patent. No. 5,429,628, Trinh et al, issued July 4, 1995,1 which is incorporated herein by reference in its entirety.
HIGHLY EFFECTIVE HUMIDITY ABSORBENTS Highly effective moisture absorbers are optionally included in the present invention to help reduce excess moisture in hidden skin and increase the flowability (the flowability without forming cake due to moisture) of the compositions of the present invention. As used herein, the phrase "highly effective moisture absorbers" refers to silicas (silicon dioxide), silicates or carbonates wherein the silicates and carbonates are formed by the reaction of a carbonate or silicate with the alkali metals (IA), alkaline earth metals (HA), or transition metals. Extremely preferred moisture absorbers are calcium silicate, amorphous silicas, calcium carbonate, magnesium carbonate, or zinc carbonate, and mixtures thereof. Some specific examples of the silicates and carbonates useful in the present invention are explained in more detail in Van Nostrand Reinhold's Encvclopedia of Chemistrv. 4th ed. pages 155, 169, 556, and 849, (1984), which is incorporated herein by reference. Synthetic versions of the highly effective moisture absorbers are preferred, particularly with respect to silicas and silicates because of the safe risks associated with crystalline silica. Synthetic versions are formed by controlled chemical reactions in a manufacturing process instead of using a natural, mined version of these compounds that is then refined. Synthetic carbonates useful in the present invention can be obtained from various suppliers such as Mallinckrodt or Whittaker, Clark, and Daniels. Examples of synthetic calcium silicates useful in the present invention are Hubersorb® 250 or Hubersorb® 600 available from J.M. Huber. It is preferred that the highly effective moisture absorbers comprise from about 5% to about 60%; most preferably, from about 10% to about 50%; and still most preferably, from about 20% to about 40% by weight of the total composition.
COMPOSITION OF PERFUME Perfume is an essential component of the present invention and is included at a level that is not irritating to the skin and / or respiratory tract of the common user, but which is detected by the human sense of smell before and / or after of the application on the skin. The perfume compositions should be safe for use on the skin. The perfume compositions useful herein comprise perfume ingredients. The perfume compositions may be in the form of free perfume, in the form of encapsulated perfume, or mixtures thereof. The perfume composition is normally present at a level of from about 0.01% to about 20% by weight of the odor absorbing composition.
Encapsulated perfume It is preferable that an effective amount, typically from about 0.05% to about 15%, preferably from about 0.1% to about 10%, most preferably from about 0.2% to about 8%, and still most preferably from about 0.5% to about 5%, in The weight of the odor absorbing composition is in the encapsulated perfume form. The encapsulated perfume helps to avoid premature loss of the perfume composition in the atmosphere as well as to avoid strong odors which may be unpleasant for the user. As used herein, the term "encapsulated perfume" refers to perfume compositions that are contained, or preferably, encapsulated in a vehicle. Examples of suitable encapsulation media for forming the perfume encapsulated herein include the formation of perfume / cyclodextrin ingredient inclusion complexes, coacervate encapsulation, cell matrix encapsulation, crude formation of porous, perfume-filled particles, and mixtures thereof. same. Encapsulated perfumes are preferably those that are released by a moisture activation mechanism where after being moistened, for example, by perspiration or other body fluids, the encapsulated perfume releases the perfume composition. Therefore, the skin irritation caused by the perfume is minimized because the encapsulated perfume is released only when it is moistened.
Perfume / cyclodextrin ingredient inclusion complexes are preferred not only because they show the preferred moisture activation release, but also because of their effectiveness and ease of processing. The perfume charge in the cyclodextrin complex is relatively low, for example, from about 10% to about 18% in perfume / beta-cyclodextrin complex. The inclusion complexes of the perfume / cyclodextrin ingredient, particle sizes, and methods of formation useful herein are described in detail in the U.S. patent. No. 5,429,628, Trinh et al, issued July 4, 1995, which is incorporated herein by reference in its entirety. At least one effective amount of the inclusion complex of the perfume / cyclodextrin ingredient should be applied to the odor absorbing compositions herein in order to be able to deliver the desired levels of perfume composition. Effective amounts are usually in the range of from about 0.01% to about 10%, preferably from about 0.1% to about 3%, most preferably from about 0.2% to about 2%, by weight of the odor absorbing composition. The encapsulation of coacervate perfume is a commonly known encapsulation method wherein a drop of one or more perfume ingredients is enclosed in a solid walled material. In the encapsulation of cell matrix perfume, a solid particle contains many small drops of one or more perfume ingredients stably contained in the cells. The water-soluble cell matrix perfume microcapsules (activated by moisture) which are preferred herein, and the preparation thereof, are described in detail in U.S. Patent No. 5,429,628, Trinh et al, issued July 4. of 1995, which is incorporated herein by reference in its entirety. Water soluble cell matrix perfume microcapsules in the present invention preferably have a size of about 0.5 microns to about 60 microns, most preferably from about 1 micron to about 50 microns, still most preferably about 2 microns.
microns to approximately 40 microns. The encapsulation of coacervate perfume and cell matrix perfume encapsulation are preferred because of its perfume charge which can be as high as 60% -80%. Effective amounts of cell matrix and / or coacervate perfume microcapsules are normally found in the
scale from about 0.002% to about 6%, preferably from about 0.007% to about 1%, most preferably from about 0.01% to about 0.5%, by weight of the odor absorbing composition. Porous particles filled with perfume formed
They are crudely used when a slow and continuous release of perfume composition is desired. The porous particles filled with perfume are perfume ingredients / compositions that are comprised in a matrix and that are released through diffusion. Porous particles
fcl- filled with starch matrix perfume can be prepared from the description with the patent of E.U.A. No. 5,267,531, Appel et al, issued December 7, 1993, which is incorporated herein by reference in its entirety. A non-limiting example of useful porous particles, starch granules, is described in Whistler et al, Food Technoloqv, July 1994, pp. 104-105, incorporated herein by reference. The porous particles filled with perfume can be coated with suitable materials to improve the retention of the perfume ingredient. The preferred particle size for the porous particles is from about 10 microns to about 60 microns, most preferably from about 15 microns to about 40 microns. Preferably, the encapsulated perfume, in any form that is present, is composed of perfume ingredients selected predominantly from two groups of ingredients, mainly, (a) volatile perfume ingredients having a normal pressure melting point of less than about 260 ° C, most preferably less than about 250 ° C, and (b) ingredients having a detection threshold of relatively low odor, and mixtures thereof. The melting points of many perfume ingredients are given in, for example, "Perfume and Flavor Chemicals (Aroma Chemicals)," Steffen Arctander, published by the author, 1969, incorporated herein by reference in its entirety. Typically, at least about 50%, preferably at least about 60%, most preferably at least about 70%, and still most preferably at least about 80% by weight of the encapsulated perfume is composed of ingredients of perfume of the previous groups (a) and (b). Non-limiting examples of the most preferred volatile perfume ingredients are allo-ocimene, allyl caproate, allyl cyclohexanacetate, allyl cyclohexanpropionate, allyl heptanoate, amyl acetate, amyl propionate, anethole, anisic aldehyde, anisole, benzaldehyde, benzyl acetate, benzyl acetone, benzyl alcohol, benzyl butyrate, benzyl formate, benzyl isovalerate, benzyl propionate, beta-hexenol,
butyl benzoate, butyl caproate, 4-tert-butylcyclohexyl formate, camphene, camphor gum, carvacrol, laevo-carveol, d-carvone, laevo-carvone, cinnamyl formate, cis-jasmona, cis-3 acetate -hexenyl, cis-3-hexenyl butyrate, cis-3-hexenyl caproate, cis-3-hexenyl tiglato, c-3-hexenyl valerate, citral (neral), citronellol, citronellyl acetate, formate
Citronellyl, citronellyl isobutyrate, citronellyl nitrile, citronellyl oxyacetaldehyde, citronellyl propionate, cuminic alcohol, cuminic aldehyde, cyclal C, cyclohexylethyl acetate, beta-damascone, 2-decane, decyl aldehyde, dihydromyrcenol, dihydromyrcenyl acetate, dimethylbenzyl carbinol, dimethylbenzyl carbinyl acetate, dimethylbenzyl carbinyl propionate, acetate
of dimethylphenylethyl carbinyl, 3,7-dimethyloctanal, dimethyl octanol, diphenyl oxide, ethyl acetate, ethyl acetoacetate, ethylamyl ketone, ethyl benzoate, ethyl butyrate, ethylhexyl ketone, ethylphenyl acetate, eucalyptol, phenyl acetate, phenolic alcohol, flower acetate (tricyclodecetyl acetate), frutene
m ^ ^ & z ^^, ^^^, ^^^^^^! ^^^^ (decency tricyclic propionate), range methyl ionone, gamma-nonalactone, geraniol, geranyl acetate, geranyl acetoacetate, butyrate of geranyl, geranyl formate, geranyl sobutyrate, geranyl nitrile, geranyl propionate, heptyl acetate, heptyl isobutyrate, heptyl propionate, hexenol, hexenyl acetate, hexenyl isobutyrate, hexyl acetate, hexyl formate, hexyl isobutyrate, hexyl isovalerate, hexyl neopentanoate, hexyl tiglato, hydratropic alcohol, hydroxycitronellal, alpha-ionone, beta-ionone, gamma-ionone, alpha-ionone, isoamyl alcohol, isobornyl acetate, isobornyl propionate, benzoate isobutyl, isobutyl caproate, isononyl acetate, isononyl alcohol, isomentol, isomenthone, isononyl acetate, isopulegol, isopulegyl acetate, isoquinoline, lauric aldehyde (dodecanal), lavandulyl acetate, ligustral, d-limonene, linalool, linalool oxide , linalil acetate or, linalyl butyrate, linalyl isobutyrate, linalyl formate, linalyl propionate, menthone, menthyl acetate, methyl acetophenone, methyl amyl ketone, methyl anthranilate, methyl benzoate, methylbenzyl acetate, methyl cavicol, eugenol methyl, methylheptanone, methyl heptin carbonate, methyl heptyl ketone, methyl hexyl ketone, alpha-iso "gamma" methyl ionone, methyl nonyl acetaldehyde, methyl octyl acetaldehyde, methyl octyl ketone, methylphenyl carbinyl acetate, methyl salicylate, myrcene, acetate of mircenyl, neral, nerol, nitrile acetate, nonalactone, nonyl butyrate, nonyl alcohol, nonyl acetate, nonyl aldehyde, octalactone, octyl acetate, octyl alcohol (octanol-2), octyl aldehyde, orange terpenes (d- limonene), para-cresol, para-cresyl methyl ether, para-cymene, para-isopropyl para-methyl acetophenone, phenethyl anthranilate, phenoxy ethanol, phenyl acetaldehyde, phenylethyl acetate, phenylethyl alcohol, feni l ethyl dimethyl carbinol, alpha-pinene, beta-pinene, alpha-terpinene, prenyl acetate, propyl butyrate, pulegone, rose oxide, safrole, alpha-terpinene, gamma-terpinene, 4-terpineol, terpineol, terpinolene, acetate of terpinyl, terpinyl propionate, tetrahydro linalool, tetrahydro mircenol, thymol, delta-undecalactone, gamma-undecalactone, undecanal, undecenal, undecyl alcohol, Veratrol, Verdox, Vertenex and viridin. Non-limiting examples of other preferred volatile perfume ingredients that can be used in the perfume compositions of the invention are amyl benzoate, beta-caryophyllene, cinnamic alcohol, diphenyl methane, dodecalactone, ethylmethylphenyl glycidate, eugenol, phenol acetate, gamma -n-methyl ionone, heliotropin, indole, isobutylquinoline, Lilial (pt-Bucinal), methyl-N-methyl anthranilate, para-methoxy acetophenone, phenethyl butyrate, pheneheptanol, phenylhexanol, and phenoxyethyl propionate. The preferred encapsulated perfume composition contains at least 5, preferably at least 6, most preferably at least 7, and still most preferably at least 8 different volatile perfume ingredients. The most common perfume ingredients that are derived from natural sources are composed of a multitude of components. When each of said materials is used in the formulation of encapsulated perfume compositions of the present invention, it is counted as a single ingredient, for the purpose of defining the invention. The use of small amounts of perfume ingredients having low odor detection threshold values can improve the perfume character of the perfume, however they are not as volatile as the perfume ingredients of group (a) described above. The term "odor detection threshold" of an odorous material refers to the lowest vapor concentration of said material that can be detected by smell. The odor detection threshold and some odor detection threshold values are discussed in, for example, "Standardized Human Olfactory Thresholds," M. Devos et al, IRL Press, Oxford University Press, 1990; and "Compilation of Odor and Taste Threshold Values Data", F. A. Fazzalari, editor, ASTM Data Series DS 48A, American Society for Testing and Materials, 1978, both publications are incorporated by reference. The perfume ingredients that do not belong to the above group (a), but which have a low odor detection threshold useful for the invention, are selected from the group consisting of ambrox di, bacdanol, benzyl salicylate, lime, cetalox, salicylate of cis-3-hexenyl, cyan, ebanol, ethyl anthranilate, ethylmethylphenylglycidate, ethyl vanillin, dihydroisojasmonate, dodecalactone range, flower acetate, florhidral, frutene, heliotropin, alpha ionone, betaionone, isoeugenol, alphaisomethylionone, lilial, lyral , methyl dihydrojasmonate, methylbetanyl ethyl ketone, betanaphthyl methyl ether, parahydroxyphenylbutanone, undecalactone range, vanillin, and mixtures thereof. These materials are preferably presented at low levels in addition to the volatile ingredients of group (a), typically less than about 20%, preferably less than about 15%, most preferably less than about 10%, by weight of the composition of fragrance. There are also volatile ingredients of group (a) that have significantly low odor detection thresholds that are useful for the present invention. Examples of these ingredients are allylamyl glycolate, anethole, benzylacetone, butyl anthranilate, cinnamic alcohol, cyclal C, cycloalbanate, 4-decane, ethyl-2-methyl butyrate, eugenol, damascenone, alphadamascona, fructone, herbavert, indole, isociclocitral , ketone, linalool, methyl anthranilate, methylheptin carbonate, methyl isobutenyltetrahydropyran, methylnonyl ketone, nerol, para-anisic aldehyde, phenylacetaldehyde, and undecylenic aldehyde.
Free perfume The perfume composition can also be in the form of a free perfume. The term "free perfume", as used herein, refers to a perfume composition that is not encapsulated. When desired, the free perfume can be diluted in a solvent to help incorporate it into the compositions. Suitable solvents include skin auxiliaries described herein and solvents found in Cosmetic Bench Reference, 1994 edition, page 54, which is incorporated herein by reference. The free perfume may be composed of conventional perfume ingredients at a level of from about 0.01% to about 5%, preferably from about 0.05% to about 3%, most preferably from about 0.05% * to about 2%, and still most preferably from about 0.1% to about 1%, by weight of the odor absorbing composition.
POWDER VEHICLE The highly effective cyclodextrins and moisture absorbers useful in the present invention should be dispersed in a pharmaceutically acceptable powder carrier for convenient, uniform application and distribution in the skin. The term "pharmaceutically acceptable", as used herein, means a powder suitable for topical use on the skin without toxicity, irritation, allergic response, and the like. The powder vehicle also helps to prevent the solubilized cyclodextrin from being removed from the desired contact of the skin. Powdered vehicles useful in the present invention include powders known in the art that are safe for human skin. Such powders include but are not limited to corn starch (topical starch), talc, rice starch, wheat starch, tapioca starch, microcrystalline cellulose (e.g. Avicel®), aluminum starch octenyl succinate (sold by National Starch &Chemical Co. as Dry Fio® Pure, Dry Fio® XT, and / or dry Fio® PC), kaolin, and mixtures thereof. Corn starch is preferred.
The powder carrier of the present invention comprises from about 10% to about 95%, preferably from about 15% to about 80%, most preferably from about 25% to about 50%, by weight of the composition.
ATTACHMENT AGENTS FOR CHECKING THE ODOR Optionally, the compositions of the present invention may comprise zeolites, carbon odor controlling agents, sodium bicarbonates, antimicrobial agents and / or antiperspirant ingredients for control of additional body odor. The term "zeolite", as used herein, refers to non-fibrous zeolites. When the present invention is included, the zeolites may be present from about 0.1% to about 25%, preferably from about 1% to about 15%, by weight of the composition. A detailed description of zeolites useful in the present invention is found in the patent of E.U.A. No. 5,429,628, Trinh et al, issued July 4, 1995, incorporated herein by reference in its entirety. The carbon agents for controlling odor described in the U.S.A. No. 5,429,628 can be used in the present invention at a level of from about 0.1% to about 25%, by weight of the composition.
~ *% "Alkali metal salts of carbonate and / or bicarbonate, such as sodium bicarbonate, potassium bicarbonate, potassium carbonate, cesium carbonate, sodium carbonate, and mixtures thereof, may be added to the composition in powder of the present invention to help control acid-type odors. An example of sodium bicarbonate and its use as an underarm deodorant is shown in the U.S. patent. No. 4,382,079, of Marschner, issued May 3, 1983, and is incorporated herein by reference in its entirety. Preferred salts are sodium carbonate monohydrate, potassium carbonate, sodium bicarbonate, and mixtures thereof. The alkali metal carbonate and bicarbonate salts are normally present at a level of from about 0.1% to about 30%, preferably from about 0.2%, to about 20%, most preferably from about 0.3% to about 10%, by weight of the powder composition. The antimicrobial agents of the present invention are selected from the group consisting of antibacterial agents, antifungal agents, and mixtures thereof. The antimicrobial agents help to destroy and / or control the amount of bacteria and / or fungus present in the skin. Preferred antimicrobial agents are zinc phenolsulfonate, zinc oxide, triclosan, Zelec® AM by DuPont, zinc ricinoleate, zinc undecylenate, and mixtures thereof. Most preferred are zinc phenolsulfonate, zinc oxide and triclosan. The triclosan is available from Ciba-Geigy as Irgasan DP-300. Examples of antimicrobial agents useful in the present invention are found in Cosmetic Bench Reference, 1994 edition, page 10, which is incorporated herein by reference. When included in the present invention, the antimicrobial agents are at a level of from about 0.01% to about 25%. Preferably from about 0.1% to 5 about 10%, by weight of the present composition. When used in the armpits, antiperspirant ingredients can be included in the present invention. Examples of antiperspirants known in the art are found in Cosmetic Bench Reference, 1994 edition, page 13, which is incorporated herein by reference.
• 10 reference. When included in the present invention, antiperspirants may be present in about 0.1% to about 25%, by weight of the composition.
AUXILIARIES FOR THE SKIN 15 The compositions of the present invention may optionally include skin aids. The term "auxiliary for the skin" as
• is used herein, refers to protectors, emollients and humectants for the skin. The skin protectors useful in the present invention are
found in Cosmetic Bench Reference, 1994 edition, page 53; and Monograph on Skin Protectant Drug Products for Over-the-Counter Human Use, 21 CFR 347. Preferred skin protectants are corn starch, kaolin, mineral oil, sodium bicarbonate, dimethicone, zinc oxide, colloidal oat, and mixtures thereof. When presented, the skin protectors comprise from about 0.1% to about 80%, preferably from about 0.1% to about 30%, most preferably from about 0.1% to about 10% by weight of the composition. The emollients and humectants useful in the present invention can be found in Cosmetic Bench Reference, 1994 edition, pages 27-32 and 46-48, incorporated herein by reference. Preferred emollients and humectants are tocopherol, tocopheryl acetate, aloe, vegetable oils, mineral oil, petrolatum, jojoba oil, and mixtures thereof. Encapsulated or spray-dried / freeze-dried emollients are preferred. The use of encapsulated or spray-dried / freeze-dried emollients keeps the emollients protected in the powder vehicle until they are released through shear stress (such as rubbing with underwear or fabrics) or through contact with moisture in the skin. Examples of preferred spray-dried / freeze-dried aloe in the present invention are Terra-Dry ™ freeze-dried aloe, Terra-Pure ™ spray-dried or freeze aloe and Terra-Spray ™ spray-dried aloe, all of Terry's previous Laboratories. When presented, the emollients / humectants comprise from about 0.1% to about 50%, preferably from about 0.1% to about 25%, most preferably from about 0.1% to about 10%, by weight of the composition.
SLIDING COMPOUNDS The present compositions may optionally comprise slip compounds. The term "slip compounds", as used herein, refers to compounds having unique structures that provide improved slip / lubrication characteristics of powders and / or reduced friction from skin to skin between intertriginous skin sites. The slip compounds of the present invention include polyethylene, nylon; polytetrafluoroethylene; silica which is in the form of microspheres, ellipsoids, barrel forms, and the like; mica, silicone (for example dimethicone) and metal stearates (for example zinc stearate); and mixtures thereof. Preferred slip compounds are silicas which are in the form of microspheres, ellipsoids, barrel shapes, and the like. The silica ellipsoids useful in the present invention are available from DuPont as ZELEC® Sil. The silica microspheres available from KOBO such as MSS-500, MSS 500/3, MSS-500 / H, MSS-500 / 3H, MSS-500 / N, and MSS-500 / 3N. Additionally, it is preferred that part of the silica of the present invention is fuming silica to increase the flowability of the powder in addition to improving the sliding characteristics. Silica fume is available from Cabot Corporation (Cab-O-Sil®) and Degussa (Aerosil®). When present in the compositions of the invention, the slip compounds comprise from about 0.1% to about 35%, preferably from about 1% to about 10%, by weight of the composition.
AGGLUTINANTS The present invention may optionally include dry or wet binders to help promote adhesion of the powder and active ingredients to the skin. The binders useful in the present invention are found in the Cosmetic Bench Reference, 1994 edition, pages 13-14, incorporated herein by reference. Preferred binders are calcium stearate, zinc stearate, isopropyl myristate, magnesium myristate, silicone, and mixtures thereof. The most preferred are zinc stearate, dimethicone, and mixtures thereof. When included in the composition, the binders are at a level of from about 0.1% to about 25%, preferably from about 1% to about 15%, by weight of the composition.
ANTI-PRURITIC AGENTS Anti-pruritic agents such as those known in the art can be included in the compositions of the present invention. Examples of anti-pruritic agents useful in the present invention are Magnesium-L-lactate, hydrocortisone, hydrocortisone acetate, and colloidal oat. A description of anti-pruritic agents is shown in Handbook of Non Prescription Druas. 10th edition, p. 529, 1993; which is incorporated herein by reference. When included in the composition, the anti-pruritic agents may be present in about 0.1% to about 40%, by weight of the composition.
COLORING Dyes and dyes can optionally be added to the odor absorbing compositions for visual appearance and performance printing. Colorants suitable for use in the present invention are found in Cosmetic Bench Reference, 1994 edition, pages 21-22, which is incorporated herein by reference.
PROCEDURE FOR PREPARING COMPOSITIONS
The compositions of the present invention are prepared by the following steps: creating a mixture by mixing cyclodextrin, any highly effective moisture absorbent, and optional ingredients in a powder vehicle through a commercially available mixer such as a v-blender, cone blender double, or batten mixer until the mixture is uniform; and creating a reduced size mix using a commercially available size reduction technique such as hammer milling, impact milling, ball milling, or milling by fluid energy until the desired particle size distribution is achieved.
The perfume composition, whether encapsulated or free, can be added to the present compositions in different ways. A suitable method for including encapsulated perfume involves the formulation of the cyclodextrin complex in the manner described in the US patent. No. 5,429,628 to Trinh et al, issued July 4, 1995, which is incorporated herein by reference, and mixing the cyclodextrin / perfume complexes with the above composition in a final or intermediate step. When desired, free perfume may be incorporated by sprinkling the cyclodextrin, carrier, or any of the powdered ingredients with the free perfume. Preferably, the free perfume is mixed with one or more of the liquid ingredients herein, such as skin aids, prior to spraying. Because the composition of the present invention should be applied directly to the skin or hair, several applicators are useful for delivering compositions throughout the body for maximum odor control. For example, the compositions are preferably deposited in a bottle, can, spray dispenser, manually activated spray dispenser, or on a cleaning structure which acquires contact with the skin to transfer the composition thereto. The bottles and cans known in the art are suitable for delivering the compositions of the present invention. The bottles and cans preferably comprise covers with small openings for convenient supply of the composition.
The composition of the present invention can also be supplied as a solution suspended through a spray dispenser or bottle, so that when applied or sprayed on the skin, the solvent will immediately dry / volatilize to leave a dust film. Examples of such suspension forms are aerosols, liquid suspensions in powder, or suspensions of silicone. When presented in an aerosol composition, the powders of the present invention are normally presented in the range of about 0.1% to about 15%, by weight of the composition. The incorporation of a powder in an aerosol is explained in greater detail in the patent of E.U.A. No. 4,078,051 of Pomot et al., Issued March 7, 1978; which is incorporated herein by reference in its entirety. Nevertheless, this method is not preferred for use in sensitive areas of the body such as the line of the panty or other hidden areas of the skin because irritations in the skin can occur by the propellants commonly used in aerosol containers. A manually activated spray dispenser is preferred which supplies the composition as a powder without the use of propellants, and without the composition being in the form of a solution. The spray dispensers useful herein are described in greater detail in the U.S.A. No. 2,450,205 of Rose, issued September 28, 1948; and the patent of E.U.A. No. 2,840,277, of Bach, issued June 24, 1958, both incorporated herein by reference in its entirety.
Any cleaning structure and / or methods for making the cleaning structures commonly known in the art can also be used. The cleaning structure comprises flexible supply means. The term "flexible supply means", as used herein, includes papers, fabrics, nonwovens, films, foams, sponges, rollers, pads, handkerchiefs, cotton balls and the like. Preferred cleaning substrates comprise a porous material, such as nonwoven substrates, foams, or sponges, which are capable of retaining the composition within the pores of the substrates. Examples of cellulosic nonwovens are described in the US patent. No. 4,191, 609, Trokhan, issued March 4, 1980, which is incorporated herein by reference in its entirety. Techniques for combining cleaning substrates with the composition of the present invention are well known in the art. Examples of common techniques include coating, immersing, soaking, splashing or spraying the cleaning substrate with the compositions herein. The composition of the present invention is added to the fabric substrate at a level sufficient to provide the desired odor control and / or other skin benefits. Packages suitable for use herein are commonly known in the art and include resealable packagings and those suitable for one-time use.
METHODS OF USE
The present invention also relates to a method for reducing body odor comprising the application of an effective amount of the compositions described herein on the skin. The present invention also comprises a method for reducing vaginal odor comprising the application of an effective amount of the compositions described herein in the pelvic region, external vagina, and / or panty line. However, the compositions of the present invention should not be inserted into the vagina, nor applied to the vulva. An "effective amount" of the compositions of the present invention, as used herein, refers to an amount sufficient to absorb body odor in order to make it less perceptible by the human sense of smell. Although the effective amount used and the number of applications per day are left to the discretion of the user, normally an effective amount will be from about 1cm3 to about 3cm3 of the odor absorbing composition per application, one to three times a day, during the days that the user wishes. The compositions herein are topically applied directly to the skin or hair. The compositions can be delivered by placing the composition in a delivery medium and applying an effective amount by spraying, splashing, shaking, or rubbing the composition on the desired skin surface; Normally throughout the body. Preferably
the supply means are a splash can, an atomizer or a preformed cleaning structure comprising flexible supply means. Alternatively, the user may deposit the composition herein in a cleaning structure comprising a flexible supply means of his choice. To accomplish this, the user selects a flexible supply means such as a cleaning cloth or sponge; transfers the composition from the bottle or other suitable container to the chosen flexible supply means, and applies the composition to the desired area of the body. The user can also use his hand to apply the compositions. The user can use the amount of composition desired, depending on the intended use and degree of odor control needed. The following non-limiting examples illustrate useful perfume compositions and odor absorbing composition formulations together with methods of use of the present invention. The perfume compositions A-G are useful for formulating as encapsulated perfume. The perfume compositions E-G can also, optionally, be used as a free perfume.
COMPOSITION OF PERFUME jT COMPOSITION OF PERFUME B
Inqredients% p Inqredients% p
Ambrox dl 10% in DPG 1.5 Benzyl acetate 2.4
Benzyl acetate 1.9 Cinnamic alcohol 0.1
Benzyl Salicylate 3.1 Cis 3 Hexenyl Acetate 0.3
Beta range Hexenol 0.4 Cis Jasmona 0.4
Cis-3-hexenyl acetate 0.5 Citronellol 4.1
Cis-3- 2.5 salicylate Citronellyl acetate 1.3 hexenyl Citronelal nitrile 1.5 Dimethyloctanol 1.6
Citronelol 9.2 Etillinalool 7.3
Ciclal C 0.9 Flower Acetate 4.9
Ciclogalbanato 0.5 Fruteno 3.3
Dihydromircenol 0.9 Geraniol 4.9
Ebanol 0.1 Helional 4.1
Eucalyptol 0.6 hexyl cinnamic aldehyde 16.0
Eugenol 0.5 Hydroxy citronella 1.6
Flower acetate 8.3 lonona methyl range 5.7
Fruteno 4.0 Iso E super 4.1
Geranil nitrile 0.3 Liral 3.3 hexyl cinnamic aldehyde 10.5 dihydro jasmonate 16.2 methyl Hydroxy citronella 2.3 0.3 methylphenylcarbinyl acetate Isobornyl acetate 0.2 P.T. Bucinal 8.9
Iso cycle geraniol 0.6 Phenylethyl alcohol 4.9
Linalool 1.9 Phenylhexanol 0.8
Linalnyl acetate 4.2 Terpineol 3.3
Methylredrilone 0.2 undecylenic aldehyde 0.2
0.9-methyl dihydrojasmonate Methyl isobutenyl-0.3 tetrahydropyran 0.9-methylphenylcarbinyl acetate Orange terpenes 17.6 P.T. bucinal 17.8 Phenylethyl alcohol 4.6 Prenyl acetate 1.2 COMPOSITION OF PERFUM C COMPOSITION OF PERFUME D
Ingredients% p Ingredients% p
Acetate of 4-ter-10.0 Acetate of 4-tert-12.3 butylcyclohexyl butylcyclohexyl Bacdanol 0.5 Ambrox DL 10% in DPG 1.6
Cetalox 0.1 anisic aldehyde 4.5
Citral 1.0 Bacdanol 0.6
CitroneloL 5.0 Cis Jasmona 0.1
Damascenone 0.3 Citronelol 6.2
Dihydromyrcenol 1.0 ethyl cinnamate 1.3
Acetate of 1.5 Ethyl Vanillin 1.7 Dimethylbenzyl Carbinyl Ethyl Vanillin 0.5 Eugenol 0.4
Geraniol 2.0 Geraniol 12.3
Geranil nitrile 0.5 Geranyl acetate 1.2
Heliotropin 5.1 Heliotropin 12.3 hexyl cinnamic aldehyde 15.4 Hexylcinnamic aldehyde 12.3 methyl ionone range 3.2 Methylone 3.5-iso isolate Super 3.5 Isobornyl acetate 1.7 Linallyl acetate 8.1 iso Eugenol 0.3 methyl anthranilate 1.5 Lactic acid aldehyde 1.2 dihydrojasmonate 20.0 Methyl acetate 0.7 methyl Methyl isobutenyl- 0.1 Methyl anthranilate 1.5 tetrahydropyran Orange terpenes 10.0 Methyl cinnamate 1.2 for methoxy acetophenone 0.4 Methyl phenyl acetate 2.7 carbinyl Vanillin 10.3 Phenylethyl alcohol 12.3 Undecalactone 0.6 Undecylen aldehyde 0.6 Vanillin 6.9
COMPOSITION OF PERFUME AND COMPOSITION OF PERFUME F Inqredients% ß Inqredients% ß Citronelol 10 Benzyl salicylate 20 Benzyl salicylate 15 Benzyl acetate 15 Benzyl acetate 10 Benzophenone 5 Benzophenone 3 Phenylethyl alcohol 10 Cedrol 2 Linalool 15 Dihydromyrcenol 10 Dihydrojasmonate 10 methyl Acetate of Flower 5 Lilial 15 Alcohol phenyl ethyl 15 Phenylethyl acetate 5 Linalyl acetate 4 Linalool 6 dihydrojasmonate 3 methyl Lilial 10 Phenylethyl acetate 2 alpha-Terpineol 5
COMPOSITION OF PERFUME G Ingredients% £ Citronelol 5 Benzyl salicylate 5 Benzyl acetate 5 Dihydromyrcenol 5 Flower acetate 5 Phenylethyl alcohol 20 Linalyl acetate 5 Linalool 5 Methyl dihydrojasmonate 5 Lilial 20 Phenylethyl acetate 1 Vanillin 6 alpha-Terpineol 8 Aldehyde Anisic 2 Cimal 3
EXAMPLE I EXAMPLE II Inqredient% p / p Inqredient% p / p
Corn Starch (Starch 35.55 Corn Starch (Starch 12.20
Topic) Topic) Silica (Microspheres) 10.00 Talc 10.00
Magnesium Carbonate 8.00 Silica (Microspheres) 10.00
Synthetic calcium silicate 20.00 Fumed silica 5.00
Fuming Silica 5.00 Zinc Fenolsulfonate 3.00
Zinc Fenosulfonate 3.00 Triclosan 0.30
Triclosan 0.20 Cyclodextrin 6.00
Nylon-12 3.00 Aloe Vera drying by 0.50 sprinkling / freezing Zinc Stearate 3.00 Magnesium Carbonate 8.00
Beta Cyclodextrin 3.00 Nylon-12 5.00
Aloe Vera dried by 0.10 Calcium silicate 20.00 aspersion / freezing Acetate microcapsules 2.00 Zinc stearate 3.00 tocopheryl Dipropylene glycol 2.00 Tocopheryl acetate 2.00 microcapsules Free perfume ** 0.15 Mineral oil 2.00
Dimethicone 5.00 Dimethicone 5.00 Encapsulated Perfume * 8.00
Example I also Example II can also comprise an anti-pruritic agent such a zeolite such as Magnesium-L-Lactate
EXAMPLE lll W EXAMPLE IV Inqredient% p / p Inqredient% p / p
Rice starch 25.00 Octenyl succinate 12.40 Mica aluminum starch 2.00 Silica (Ellipsoids) 8.00
Silica (Ellipsoids) 14.50 Silica Fumante 8.00
Fuming Silica 5.00 Zinc Fenosulfonate 7.00
Triclosan 0.10 Triclosan 0.60
Aluminum Hydrochloride 5.00 Cyclodextrin 10.00
Cyclodextrin 6.00 Aloe Vera Gel / Oil 1.00
Aloe Vera, dried by 1.00 Magnesium Carbonate 7.00 sprinkling / freezing Calcium Carbonate 10.00 Calcium Carbonate 3.00
Polyethylene powder 3.00 Polyethylene powder 7.00
Calcium Silicate 10.00 Calcium Silicate 15.00
Zinc Stearate 7.00 Zinc Stearate 5.00
Dimethicone 10.00 Mineral Oil 5.00
Encapsulated Perfume * 1.00 Dimethicone 6.00
Free Perfume ** 0.40 Encapsulated Perfume * 4.00 Free Perfume ** 1.00
Example III may also comprise a colorant
EXAMPLE V "% *" EXAMPLE VI
Ingredient% p / p Ingredient% p / p
Tapioca starch 10.00 Corn starch 10.00 (Topical starch) Talcum 4.90 Wheat flour / oats 8.35 colloidal Silica (Microspheres) 20.00 Silica (Microspheres) 5.00
Silica Fumante 2.00 Silica (Ellipsoids) 10.00
Zinc Oxide 4.00 Silica Fumante 5.00
Triclosan 1.00 Zinc Oxide 2.00
Cyclodextrin 4.00 Triclosan 0.40
Aloe Vera Gel / Oil 2.00 Cyclodextrin 5.00
Magnesium Carbonate 5.00 Aloe Vera gel / oil 2.00
Calcium Carbonate 4.00 Magnesium Carbonate 4.00
Nylon-12 10.00 Calcium Carbonate 5.00
Calcium Silicate 15.00 Nylon-12 4.00
Zinc Stearate 6.00 Polyethylene Powder 4.00
Isopropyl Myristate 4.00 Calcium Silicate 10.00
Dimethicone 5.00 Zinc Stearate 10.00
Encapsulated Perfume * 3.00 5.00 Tocoferyl acetate microcapsules Free Perfume ** 0.10 Dimethicone 10.00 Free Perfume ** 0.25 Example VI may also comprise sodium bicarbonate
EXAMPLE VII EXAMPLE VIII
Inqredient% p / p Inoredient% p / p
Corn starch 6.80 Corn starch 43.10 (Topic starch) Caolina 4.00 Silica (Microspheres) 30.00
Silica (Microspheres) 5.00 Zinc Fenolsulfonate 3.00
Silica (Ellipsoids) 5.00 Triclosan 0.30
Silica Fumante 5.00 Nylon-12 10.00
Zinc Fenolsulfonate 2.00 Beta Cyclodextrin 3.00
Triclosan 0.20 Tocofenlo 5.00 acetate microcapsules Cyclodextrin 8.00 Dipropylene glycol 0.30
Aloe Vera Gel / Oil 3.00 Free Perfume ** 0.30
Magnesium Carbonate 10.00 Dimethicone 5.00
Nylon-12 2.00 Polyethylene Powder 5.00 Calcium Silicate 25.00 Zinc Stearate 7.00 Tocopheryl Acetate 3.00 Microcapsules Isopropyl Myristate 2.00 Dimethicone 5.00 Encapsulated Perfume * 2.00
EXAMPLE IX Ingredient% p / p Corn Starch (Topic Starch) 47.50 Silica (Microspheres) 40.00 Triclosan 0.30 Zinc Stearate 3.00 Beta Cyclodextrin 3.00 Dipropylene Glycol 0.60 Free Perfume ** 0.60 Dimethicone 5.00
i? -j ¡If? ili TÍßÉir n'ri EXAMPLE X EXAMPLE XI Inqredient% p / p Inqredient% p / p
Corn starch (Starch 60.80 Corn starch 50.00
Topic) (Topic Starch) Silica (Microspheres) 2.00 Talc 10.00
Silica Fumante 2.00 Silica (Microspheres) 3.00
Zinc Fenolsulfonate 3.00 Silica Fumante 1.00
Triclosan .20 Zinc Fenolsulfonate 3.00
Cyclodextrin 3.00 Triclosan 0.30
Aloe Vera, dried by 1.00 Cyclodextrin 13.00 aspersion / freezing Nylon-12 5.00 Aloe Vera, dried by 0.50 aspersion / freezing Zinc Stearate 7.00 Nylon-12 5.00
Acetate Microcapsules 2.00 Zinc Stearate 3.00 Tocopheryl Dimethicone 10.00 Microcapsules 2.00 Tocopheryl Acetate Encapsulated Perfume * 4.00 Mineral Oil 2.00 Dimethicone 5.00 Free Perfume ** 0.20 Encapsulated Perfume * 2.00 Example X also Example VI can also comprise a can comprise a zeolite coloring
EXAMPLE XII
Ingredient% p / p Rice Starch 51.00 Mica 2.00 Silica (Ellipsoids) 2.00 Fuming silica 1.00 Triclosan 0.50 Aluminum chlorohydrate 5.00 Cyclodextrin 6.00 Aloe Vera, 1.00 freeze dried / sprayed Polyethylene powder 5.00 Zinc stearate 5.00 Tocopherol acetate oil ( acetate or 00 of vitamin E) Dimethicone 10.00 Nylon N-12 5.00 Free perfume ** 0.50 Encapsulated perfume + 3.00
EXAMPLE XIII
Ingredient% p / p Octenyl starch of 30.20 aluminum Succinate (Dry Fio® Puree) Silica (Ellipsoides) 4.00 Zinc phenolsulfonate 7.00 Triclosan 0.60 Cyclodextrin 10.00 Aloe Vera gel / oil 1.00 Zeolite 10.00 Talc 13.60 Polyethylene powder 7.00 Zinc stearate 5.00 Oil mineral 5.00 Dimethicone 6.00 Free perfume ** 0.60
The composition of Example VII may also comprise a zeolite.
EXAMPLE XIV
Ingredient% p / p Tapioca starch 46.50 Talc 4.90 Silica (microspheres) 2.50 Fuming silica 2.00 Zinc oxide 4.00 Triclosan 1.00 Cyclodextrin 4.00 Aloe Vera gel / oil 2.00 Nylon-12 10.00 Zinc stearate 6.00 Isopropyl myristate 4.00 Dimethicone 5.00 Free perfume * * 0.10 Encapsulated perfume * 8.00
EXAMPLE XV
Ingredient% w / w Corn starch (starch 29.00
topic) Oatmeal / cereal 16.35 colloidal oats Silica (microspheres) 2.50 Silica (ellipsoids) 1.50 Kaolin 8.00 Zinc oxide 2.00 Triclosan 0.40 Cyclodextrin 5.00 Aloe Vera gel / oil 2.00
Nylon-12 4.00 Polyethylene powder 4.00 Zinc stearate 10.00 Tocopheryl acetate 5.00 Microcapsules Dimethicone 10.00 Free perfume ** 0.25 EXAMPLE XVI
Ingredient% w / w Corn starch (topical 49.00 starch) Kaolin 14.50 Silica (microspheres) 2.50 Silica (ellipsoids) 1.50 Fuming silica 0.50 Zinc phenolsulfonate 2.00 Triclosan 0.20 Ciclodextrin 8.00 Aloe Vera gel / oil 3.00 Nylon-12 2.00 Polyethylene powder 5.00 Tocopheryl acetate 3.00 Microcapsules 10 Isopropyl myristate 2.00 Dimethicone 5.00 Free perfume ** 0.80 Encapsulated perfume * 1.00
* Any perfume encapsulated in Examples I-XVI may comprise any of the perfume compositions of Examples A-15 G. ** Any free perfume in Examples I-XVI may comprise any of the perfume compositions of Examples E- G. The above examples are prepared by the following
steps: a first mix is created, mixing the cyclodextrin, ingredients
dry and a powder vehicle in a commercially available mixer, such as a V-blender, double-cone mixer or ribbon blender until the mixture is uniform; the particle size of the
mixing using a grinding / spraying technique such as hammer grinding, impact grinding, trituration by ball or grinding with fluid energy; and a second mixture is created by adding any emollient, humectant and / or skin protectants from the liquid phase to the mixture, preferably using spray atomization while continuing to mix for a more uniform dispersion. The second mixture may be subjected to a second spraying / milling step, and if desired, an air sorting operation. When the above examples include free perfume compositions, the creation of the second mixture may include the addition of the perfume compositions in the liquid phase. When the above examples include encapsulated perfume, the encapsulated perfume can be added with the dry ingredients when the first mixture is created; or, preferably, it can be added in a final step of creating a third mixture by adding the encapsulated perfume to the second mixture with mixing.
Preparation for application to the skin: The compositions of the present invention, such as those formed from the examples, can be loaded onto a cloth or deposited in a spray device or box. The compositions can be applied directly on the skin or on a flexible delivery medium chosen by the user for convenient application to the skin. To prepare the cloths, the composition is applied, splashed or sprayed onto a flexible supply medium until the desired coating or thickness of the composition is achieved on the flexible supply medium. For the spray, the composition is deposited in the selected spray pack. The packaging is closed for storage until it is used by the consumer. To prepare a pressurized aerosol spray, the composition is transferred into a suitable container. The container is sealed and pressurized after injection of the propellant materials.
EXAMPLE XVII
A woman with urinary stress incontinence discovers that the moisture associated with this condition causes vaginal odor that she wants to remove from the skin and control. After urinating, the woman cleans her outer vagina and pelvic region with a cloth containing the composition in Example X. This woman notes less odor after using the cloth.
EXAMPLE XVIII
An obese woman with large breasts finds that when she exercises she tends to experience sweating and skin irritation under the breasts. Before and after exercise, apply the composition of example III or IX by means of a spray bottle. Spray the perfumed composition under her breasts. The woman also applies the composition in interstitial regions between her abdominal skin folds, as well as in other occluded skin sites. She notes less odor and excess moisture after using the powder spray.
EXAMPLE XIX
A man has severe allergies to cosmetic deodorants, antiperspirants, strong colognes, and avoids the use of such products. The above results in an uncontrolled and shameful body odor. Your doctor suggests you apply the mild odor absorbing composition of Example I or XV after bathing. The man applies the composition throughout his body by spraying every morning after bathing, and does not suffer any allergic reaction. The man feels comfortable without the shame of an uncontrollable and persistent body odor. The man keeps a small bag of cloths that also contain the composition of example I or XV, for a convenient and discreet reapplication as necessary.
SaJ-fe - gj
Claims (13)
1. - An odor absorbing composition comprising: a) about 0.1% to 25%, by weight of the composition, of cyclodextrin that does not form complexes; b) a perfume composition selected from the group consisting of from about 0.05% to 15%, by weight of the composition, of an encapsulated perfume, about 0.01% to 5%, by weight of the composition, of free perfume; and mixtures thereof; and c) a powder vehicle; wherein the encapsulated perfume comprises one or more volatile perfume ingredients each having a boiling point of less than about 260 ° C, ingredients having low odor detection threshold values, and mixtures thereof.
2. The composition according to claim 1, further comprising 5% to 60%, by weight of the composition, of a highly effective moisture absorbent.
3. The composition according to claim 2, further characterized in that the highly effective moisture absorbers are selected from the group consisting of silicates, silicas and carbonates.
4. The composition according to any of the preceding claims, further characterized in that the cyclodextrin is selected from the group consisting of beta-cyclodextrin, beta-cyclodextrin derivatives, alpha-cyclodextrin, alpha-cyclodextrin derivatives, gamma-cyclodextrin, gamma-cyclodextrin derivatives and mixtures thereof.
5. The composition according to any of the preceding claims, further characterized in that the particle sizes are from 1 miera to 100 micras.
6. The composition according to any of the preceding claims, further characterized in that the particle sizes of the cyclodextrin are from 1 miera to 12 microns.
7. The composition according to any of the preceding claims, further comprising optional ingredients selected from the group consisting of zeolites, activated carbon, sodium bicarbonate, antimicrobial agents, antiperspirants, skin protectants, emollients, humectants and sliding compounds .
8. A composition preformed for cleaning by rubbing, characterized in that the composition according to any of the preceding claims is deposited on a cloth comprising a flexible supply means.
9. The composition according to any of the preceding claims, which is supplied as a powder by a manually activated spray dispenser.
10. The use of the compositions according to any of the preceding claims for the manufacture of a composition Moisture and odor absorber, which is safe to use on the skin, wherein the composition is applied on the skin to reduce body odor and / or vaginal odor.
11. The use according to claim 10, wherein the composition is applied on a pelvic region, external vagina and / or panty line.
12. The use according to claim 10 or 11, wherein the composition is applied to the skin using a manually activated spray dispenser.
13. A process for making an odor and moisture absorbing composition, comprising the steps of: a) making a first mix by mixing a powdered vehicle, highly effective moisture absorbers and cyclodextrin in a commercially available mixer until uniform; b) create a reduced size mix by applying a commercially available size reduction technique to the first mix until a desired particle size distribution is achieved; and c) creating a perfumed powder composition by spraying the reduced size mix with free perfume and mixing. ^^^ jt = á ^ é ^^^? m - ^^ - ^ & ^^^,
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08871092 | 1997-06-09 | ||
| US08871861 | 1997-06-09 | ||
| US08871856 | 1997-06-09 | ||
| US871790 | 1997-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA99011488A true MXPA99011488A (en) | 2001-12-04 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5861143A (en) | Methods for reducing body odors and excess moisture | |
| US5861146A (en) | Method for reducing body odor | |
| US5861144A (en) | Perfumed compositions for reducing body odors and excess moisture | |
| CA2293663A1 (en) | Perfumed compositions and methods for reducing body odors and excess moisture | |
| US5885599A (en) | Methods and compositions for reducing body odors and excess moisture | |
| US5780020A (en) | Methods and compositions for reducing body odor | |
| AU733865B2 (en) | Perfumed one and two phase compositions for reducing body odor and methods of use thereof | |
| WO1998018439A1 (en) | Compositions for reducing body odors and excess moisture | |
| WO1998018439A9 (en) | Compositions for reducing body odors and excess moisture | |
| US6004584A (en) | Highly absorbent body powders | |
| US5874070A (en) | Compositions for reducing body odor | |
| US5871718A (en) | Perfumed two phase compositions for reducing body odor | |
| US5897854A (en) | Methods for reducing body odor | |
| HUP0004525A2 (en) | Procedures for reducing environmental odors on the body by using preparations containing non-complex cyclodextrins and perfume | |
| CZ289379B6 (en) | Odor absorbing aqueous composition, a pre-formed odor absorbing wipe and process for preparing such odor absorbing aqueous composition | |
| US5861147A (en) | Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume | |
| WO2000035413A1 (en) | Methods of absorbing body odors using silica containing body powders | |
| CN1261786A (en) | Ferfumed compositions and method for reducing body odors and excess moisture | |
| MXPA99011488A (en) | Perfumed compositions and methods for reducing body odors and excess moisture | |
| KR20000052842A (en) | Compositions for reducing body odors and excess moisture | |
| CZ441499A3 (en) | Body odors absorbing preparations containing cyclodextrin, perfume composition and powder carrier and method of their application | |
| MXPA99003982A (en) | Compositions for reducing body odors and excess moisture | |
| HUP9904072A2 (en) | Preparations to reduce body odor and excessive sweating | |
| MXPA99011486A (en) | Perfumed one and two phase compositions for reducing body odor and methods of use thereof | |
| CZ441199A3 (en) | Single-phase or two-phase liquid perfume preparations absorbing body odors and method of their application |